Literature DB >> 8029170

Cardiac tamponade after thrombolysis.

T D Heymann1, W Culling.   

Abstract

Thrombolysis has been very effective in reducing the morbidity and mortality from acute myocardial infarction. Serious adverse events are not uncommon, however. We describe a case in which a haemopericardium and tamponade developed in a patient with a history of recurrent idiopathic pericarditis and to whom streptokinase had been administered following a suspected myocardial infarction. The case highlights the need for caution in the administration of thrombolytics to patients with a documented history of pericarditis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8029170      PMCID: PMC2397717          DOI: 10.1136/pgmj.70.824.455

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  4 in total

1.  Cardiovascular complications of thrombolytic therapy in patients with a mistaken diagnosis of acute myocardial infarction.

Authors:  J C Blankenship; A K Almquist
Journal:  J Am Coll Cardiol       Date:  1989-11-15       Impact factor: 24.094

2.  Cardiac tamponade early after thrombolysis for acute myocardial infarction: a rare but not reported hemorrhagic complication.

Authors:  J Renkin; B de Bruyne; E Benit; J M Joris; M Carlier; J Col
Journal:  J Am Coll Cardiol       Date:  1991-01       Impact factor: 24.094

3.  Pericardial effusion after intravenous recombinant tissue-type plasminogen activator for acute myocardial infarction.

Authors:  R N Belkin; D B Mark; L Aronson; H Szwed; R M Califf; J Kisslo
Journal:  Am J Cardiol       Date:  1991-03-01       Impact factor: 2.778

4.  Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1988-08-13       Impact factor: 79.321

  4 in total
  1 in total

Review 1.  A systematic review and pooled analysis of CPR-associated cardiovascular and thoracic injuries.

Authors:  Andrew C Miller; Shannon F Rosati; Anthony F Suffredini; David S Schrump
Journal:  Resuscitation       Date:  2014-02-10       Impact factor: 5.262

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.